Beck Bode LLC’s Amgen AMGN Stock Holding History

Beck Bode LLC’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-200	Closed	-$51K	–	17
2020 Q3	$51K	Buy	+200	New	+$49.5K	0.02%	104

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Beck Bode LLC's AMGN Position: Q4 2020 in Review

Beck Bode LLC sold out of Amgen (AMGN) in Q4 2020, closing a stake of 200 shares — an estimated $51K sold.

Beck Bode LLC first reported a position in AMGN in Q3 2020 and held it in 1 quarter. The position peaked at $51K in Q3 2020. 2,220 funds tracked by Wall St. Rank hold AMGN as of Q4 2020.

Beck Bode LLC reported no remaining Amgen position as of Q4 2020 after selling out during the quarter.
Beck Bode LLC sold 200 Amgen shares in Q4 2020, an estimated $51K.
Beck Bode LLC first reported a position in Amgen in Q3 2020 and held it in 1 quarter.
Beck Bode LLC's Amgen position peaked at $51K in Q3 2020.
2,220 funds tracked by Wall St. Rank held Amgen as of Q4 2020.

Based on Beck Bode LLC's 13F filing for Q4 2020.